1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. HALOZYME THERAPEUTICS INC.
Halozyme Therapeutics Inc. XNAS: HALO

Halozyme Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Mid-range Performer
about

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary ...

Read More
57.65 0.50 (0.87%)
35.17% Gain from 52W Low
1.1M
XNAS Volume

XNAS 14 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Insider Trade
Helen Torley, President & CEO of Halozyme Therapeutics, sells 60K shares worth $3.4 million See details
Durability score
High Financial Strength
83.3 / 100
Valuation Score
Mid Valuation
43.3 / 100
Momentum Score
Technically Neutral
55.8 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
66
1Yr Price target upside is 14%
9 analysts

13

S

5

W

0

O

3

T

SWOT Analysis

Halozyme Therapeutics Inc. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..